UNDERSTANDING THE PROPENSITY OF SEQUENCE VARIANTS DURING CELL LINE AND CULTURE PROCESS DEVELOPMENT

Sequence variants (SVs) are protein isoforms that contain one or more unintended amino acid substitutions. They can arise at a single amino acid site due to a genetic (RNA/DNA) mutation or at multiple amino acid locations, potentially due to translational errors, also referred to as misincorporations. The ability to detect SVs in protein biotherapeutics is critical due to their potential impact on structural/functional characteristics, safety, and efficacy. Trypsin peptide mapping with liquid chromatography-ultrahigh resolution tandem mass spectrometry (LC-MS/MS) provides the ideal workflow for the detection, identification, and relative quantitation of both genetic and translational SVs. 
Watch Now

Spotlight

OTHER ON-DEMAND WEBINARS

Bridging the gap between ortho and restorative treatment

Invisalign GO

The practitioner who wishes to get started in GDP orthodontics faces a bewildering array of choices: clear aligners or fixed appliances? Which product is best to get started with? How to overcome one’s poor foundation of orthodontic knowledge from undergraduate training, when much of the information learned for final exams has subsequently been forgotten? Since 2001, the Invisalign product has been used to treat over 5 million cases worldwide. This vast bank of clinical experience is constantly used to refine and improve the product, and also makes the Invisalign system the most streamlined experience for a new user who is improving their orthodontic skills and the safest place to re-start one’s journey in orthodontics.
Watch Now

Realizing The Opportunity To Increase Quality And Improve Efficiency Of Safety Data Collection Within Patient Support Programs

pharmaintelligence

Patient Support Programs (PSPs) have changed dramatically over the past decade; they have become global activities, and grown significantly in scale and complexity. While PSPs are also an increasingly valuable resource for pharmacovigilance due to the extensive patient safety data they generate, they have suffered from the traditional lack of standardized mechanisms for recording, reconciling and managing this data, resulting in resource heavy processes, and a lost opportunity for deeper product understanding for Pharma. Fortunately, new technologies are helping to tackle this challenge.
Watch Now

Getting started in 3D - Setting up your lab and reviewing common pitfalls of researchers new to 3D

Thermo Fisher Scientific

As we develop new methods to create more biologically relevant models for research in understanding disease etiology and innovating new treatment options, one of the most requested areas for educational materials is 3D cell models such as organoid and spheroid systems. Thermo Fisher Scientific is proud to present our webinar series on 3D culture & analysis, and more importantly, how you can get started, how to monitor and analyze 3D models and what to do with these once you have successfully cultured your organoid or spheroid model of interest. In this series we will specifically cover the following areas and after taking part in the presentations, hopefully you will be better equipped to answer the basic questions and feel enabled to get started using 3D culture systems.
Watch Now

FDA Drug Topics: Frequently Asked Questions about Labeling for Prescription Medicines

FDA’s Division of Drug Information in the Center for Drug Evaluation and Research (CDER) is excited to present a series of educational webinars targeting the needs of all health care professionals and students, including physicians, physician assistants, nurses, pharmacists, and pharmacy technicians.
Watch Now